Role of Immunotherapy in Pulmonary Angiosarcoma: A Case Report

Pulmonary angiosarcoma is a rare clinical entity with a poor prognosis and no established therapeutic strategies. We present the first case to our knowledge of metastatic pulmonary angiosarcoma, treated with checkpoint inhibitor immunotherapy, and have an excellent response. Until now, patient has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Quang Tien, Pham, Anh Tuan, Nguyen, Thuy Thi, Nguyen, Tam Thi Thanh, Van Le, Ky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255737/
https://www.ncbi.nlm.nih.gov/pubmed/34248542
http://dx.doi.org/10.1159/000516402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255737/
https://www.ncbi.nlm.nih.gov/pubmed/34248542
http://dx.doi.org/10.1159/000516402

Ejemplares similares